Actively Recruiting
ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer
Led by Sahlgrenska University Hospital · Updated on 2023-12-08
600
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Anal cancer is a rare but increasing disease, with about 200 new patients yearly in Sweden. This research aims to understand the quality of life and functional outcomes in patients diagnosed with anal cancer. The study focuses on identifying early side effects from treatment and long-term health issues after diagnosis and treatment. The study involves patients diagnosed with anal cancer who will be invited to participate after identification at a national tumor board. Participants will complete questionnaires about their quality of life, urinary, bowel, and sexual function at multiple time points: at diagnosis, then 3, 12, 36, 60, and 120 months after diagnosis. Participants will be followed and asked to fill out these questionnaires over several years to monitor changes and outcomes related to their condition and treatment. Researchers will measure quality of life and bodily functions at 3 months, 12 months, and 3 years after diagnosis to understand treatment toxicity and long-term effects. The study may continue up to 2035, providing long-term data on patient outcomes.
CONDITIONS
Brief Title
ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18 years
- Anal squamous carcinoma diagnosed within the last 2 months
You will not qualify if you...
- No informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 10 years
Participants complete questionnaires about quality of life and functions related to urinary, bowel, and sexual health.
Visits at 0, 3, 12, 36, 60, and 120 months
Trial Site Locations
Total: 1 location
1
Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Gothenburg, Sweden, SE 416 85
Actively Recruiting
Research Team
E
Eva Angenete
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here